Preliminary revenue results for St. Jude’s fourth quarter see it expecting to report overall net sales growth with starring performances from Atrial Fibrillation
Neuro
New Study Says Clot Extraction Beats tPA in Stroke Treatment
Intra-arterial stroke treatment was significantly more effective than medical management with tissue plasminogen activator (tPA), the current standard of care.
New Study Compares Dural Sealing Technologies
A new paper suggests that TissuePatchDural film is at least as effective as gel-based approaches to adjunctive dural closure following neurosurgery.
2014 Prix Galien Award for Best Medical Technology goes to Stryker for Neuro Clot Remover
Stryker’s clever neuro blood-clot removal device has received the Prix Galien USA 2014 Award for Best Medical Technology.
FDA Approves Pivotal Study to Investigate Dual Ablation Approach in Non-Paroxysmal Afib Patients
AtriCure will investigate a minimally invasive approach to treat patients with persistent or long-standing persistent atrial fibrillation who have failed antiarrhythmic drug therapy.
First Arteriovenous Malformation Radiosurgery with New Brainlab Software
Brainlab’s new Elements SmartBrush® Angio system uses sophisticated imaging software to facilitate AVM surgery and has been used clinically for the first time in an Irish Hospital.
First Disposable Neuro Forceps with Dual Irrigation Launched by Codman Neuro
New disposable SPETZLER™ MALIS® Dual Irrigating Bipolar Forceps claims improved visualization during Neurosurgery
Third Time Lucky as FDA Panel Votes Yes to WATCHMAN™ LAA Device
Expert Panel review has culminateded in a vote in favour of Boston Scientific Corporation’s WATCHMAN™ Left Atrial Appendage Closure Device.
TAVR: First Patient Treated in U.S. Cerebral Protection Pivotal Trial
Randomized controlled SENTINEL Trial is the first in the U.S. to study capture and removal of debris released during TAVR that may otherwise be the source of stroke
New Trials Underscore Covidien’s Neurovascular Intentions
Covidien has announced the start of enrollment in two clinical trials that it says further underscores the safety and effectiveness of the company’s advanced neurovascular solutions.
CLEAN-TAVI Trial Results Could See Embolic Protection Become Standard in TAVR
The fact that Claret Medical’s Cerebral Protection system is not yet approved for use in U.S. TAVR procedures looks like an anachronism following study results that point to a high risk procedure and a solution that works.
Codman Neuro Expands Aneurysm Portfolio with PulseRider® Distribution Deal
J&J’s Codman Neuro tells us it has entered into an exclusive distribution agreement with Pulsar Vascular to market and promote the PulseRider® wide neck aneurysm device in Europe, the Middle East and Africa.
Claret’s CLEAN-TAVI Cerebral Protection Study Sees Patient Enrollment Completed
Claret Medical™, Inc. says the CLEAN-TAVI clinical trial is the first randomised, controlled trial to investigate the importance of cerebral protection during TAVI procedures.
Codman Neuro’s REVIVE™ SE Thrombectomy Device Approved in China, South Korea and Taiwan
J&J’s Codman Neuro has gained a clutch of Far Eastern regulatory approvals for its REVIVE™ SE Thrombectomy Device for restoring blood flow in patients with acute ischemic stroke secondary to intracranial occlusive vessel disease.
Medtronic Bolts on Sapiens Steering Brain Stimulation for $200 Million
Medtech Titan Medtronic has acquired Dutch Neuro device developer and its novel Deep Brain Stimulation system
New Money Will Get Claret’s Sentinel™ Stroke Protection Device Through Study
It’s full steam ahead for Claret Medical as it announces Series B financing that will take it a long way down the road to US FDA approval, assuming its pivotal study goes to plan.